Sokol RJ, Gonzales EM, Kamath BM, Baker A, et al. Predictors of 6-year event-free survival in alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor. Hepatology 2023 Jun 7. doi: 10.1097/HEP.0000000000000502.
PMID: 37278241